Ullah, Sultan, Kang, Dongwan, Lee, Sanggwon, Ikram, Muhammad, Park, Chaeun, Park, Yujin, Yoon, Sik, Chun, Pusoon, and Moon, Hyung Ryong
Abstract Of the three enzymes that regulate the biosynthesis of melanin, tyrosinase and its related proteins TYRP-1 and TYRP-2, tyrosinase is the most important because of its ability to limit the rate of melanin production in melanocytes. For treating skin pigmentation disorders caused by an excess of melanin, the inhibition of tyrosinase enzyme is by far the most established strategy. Cinnamic acid is a safe natural product with an (E)-β-phenyl-α,β-unsaturated carbonyl motif that we have previously shown to play an important role in high tyrosinase inhibition. Since cinnamic acid is relatively hydrophilic, which hinders its absorption on the skin, fifteen less hydrophilic cinnamic amide derivatives (1 – 15) were designed as safe and more potent tyrosinase inhibitors and were synthesized through a Horner-Wadsworth-Emmons reaction. The use of conc -HCl and acetic acid for debenzylation of the O -benzyl-protected cinnamic amides 40 – 54 produced the following three results. 1) Cinnamic amides 43 , 48 , and 53 with a 2,4-dibenzyloxyphenyl group, irrespective of the amine type of the amides, produced complex compounds with high polarity. 2) Cinnamic amides 40 – 42 , 44 , 50 – 52 , and 54 with a benzylamino, or diethylamino group produced the desired debenzylated cinnamic amides 1 – 3 , 5 , 10 – 13 , and 15. 3) Cinnamic amides 45 – 47 , and 49 with an anilino moiety provided 3,4-dihydroquinolinones 16 – 19 through intramolecular Michael addition of the anilide group. Notably, the use of BBr 3 as an alternative debenzylating agent for debenzylation of cinnamic amides 45 – 49 with the anilino moiety provided our desired cinnamic amides 6 – 10 without inducing the intramolecular Michael addition. Debenzylation of cinnamic amides 43 , 48 , and 53 with a 2,4-dibenzyloxyphenyl group was also successfully accomplished using BBr 3 to give 4 , 9 , and 14. Among the nine compounds that inhibited mushroom tyrosinase more potently at 25 μM than kojic acid, four cinnamic amides 4 , 5 , 9 , and 14 showed 3-fold greater tyrosinase inhibitory activity than kojic acid. The docking simulation using tyrosinase indicated that these four cinnamic amides (−6.2 to −7.9 kcal/mol) bind to the active site of tyrosinase with stronger binding affinity than kojic acid (−5.7 kcal/mol). All four cinnamic amides inhibited melanogenesis and tyrosinase activity more potently than kojic acid in α-MSH-stimulated B16F10 melanoma cells in a dose-dependent manner without cytotoxicity. The strong correlation between tyrosinase activity and melanin content suggests that the anti-melanogenic effect of cinnamic amides is due to tyrosinase inhibitory activity. Considering that the cinnamic amides 4 , 9 , and 14 , which exhibited strong inhibition on mushroom tyrosinase and potent anti-melanogenic effect in B16F10 cells, commonly have a 2,4-dihydroxyphenyl substituent, the 2,4-dihydroxyphenyl substituent appears to be essential for high anti-melanogenesis. These results support the potential of these four cinnamic amides as novel and potent tyrosinase inhibitors for use as therapeutic agents with safe skin-lightening efficiency. Graphical abstract Image 1 Highlights • Fifteen cinnamic amide derivatives were designed and synthesized via Horner-Wadsworth-Emmons reaction. • Their anti-melanogenic effect were evaluated in mushroom tyrosinase and α-MSH-stimulated B16F10 melanoma cells. • Compound 4 , 5 , 9 and 14 revealed excellent anti-melanogenic effect as compared to kojic acid, used as positive control. • The docking study expressed that cinnamic amides bind to the active site of tyrosinase with strong binding affinity. [ABSTRACT FROM AUTHOR]